Harnessing oncolytic virus-mediated immunity

Oncolytic viruses (OVs) have emerged as a promising anticancer treatment. OVs selectively infect, replicate in, and kill tumor cells. Oncolytic viral therapy occurs in two phases: an initial phase where the virus mediates direct oncolysis of tumor cells, and a second phase where an induced post-onco...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Volker Schirrmacher, Philippe Fournier
Format:	Online
Sprache:	Englisch
Veröffentlicht:	Frontiers Media SA 2021
Schlagworte:	R5-920 RC581-607 RC254-282 anti-tumor activity immunovirotherapy oncolytic virus oncolytic virotherapy tumor-associated antigen immunotherapeutic approaches anti-viral response thema EDItEUR::M Medicine and Nursing
Online-Zugang:	18596
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!